Neftaly Best Practices for Blood Product Testing
At Neftaly, ensuring the safety, efficacy, and quality of blood and blood products is at the heart of everything we do. Our best practices for blood product testing are grounded in international standards and guided by the principles of safety, accuracy, and reliability.
We follow a systematic, evidence-based approach to testing that minimizes risks, ensures compliance, and supports optimal patient outcomes.
Our Best Practices in Blood Product Testing
???? 1. Rigorous Donor Screening and Pre-Donation Testing
- Comprehensive health assessments and donor interviews to identify potential risk factors.
- Pre-donation testing includes hemoglobin levels, blood group typing, and infectious disease risk profiling.
- Use of validated questionnaires aligned with WHO and national blood safety guidelines.
???? 2. Infectious Disease Screening
- Every unit of donated blood is screened for transfusion-transmissible infections (TTIs) such as:
- HIV (1 & 2)
- Hepatitis B and C
- Syphilis
- Malaria (where applicable)
- Neftaly uses both enzyme immunoassays (EIA) and nucleic acid testing (NAT) to enhance sensitivity and reduce the window period of detection.
???? 3. Blood Grouping and Compatibility Testing
- ABO and RhD grouping for all donations using dual testing methods.
- Antibody screening and crossmatching for recipient compatibility.
- Identification of rare and irregular antibodies to prevent hemolytic transfusion reactions.
???? 4. Quality Control of Reagents and Equipment
- All reagents are validated, stored, and monitored as per manufacturer and regulatory guidelines.
- Equipment undergoes routine calibration, maintenance, and performance validation.
- Daily internal QC and periodic external quality assessments ensure consistent test accuracy.
???? 5. Documentation and Traceability
- Test results are meticulously documented and electronically stored in a secure Laboratory Information Management System (LIMS).
- Each test result is traceable to the specific donation, reagents, and personnel involved.
- Non-conforming results trigger immediate review and corrective action.
???? 6. Continuous Staff Training and Competency Assessment
- Laboratory personnel receive regular training on new technologies, updated protocols, and safety measures.
- Ongoing competency evaluations and proficiency testing ensure that staff maintain high standards of practice.
???? 7. Rapid Response to Positive or Inconclusive Results
- Any reactive or inconclusive results are retested using confirmatory methods.
- Donors are notified with care and confidentiality, and deferred as per policy.
- Contaminated or non-compliant units are immediately quarantined and safely discarded.
Why Neftaly’s Approach Stands Out
- Alignment with WHO Blood Safety Guidelines, ISO 15189, and local regulatory authorities.
- Investment in advanced testing technologies for early and accurate detection.
- Culture of excellence, compliance, and continuous improvement.


